0001104659-22-130631.txt : 20221228
0001104659-22-130631.hdr.sgml : 20221228
20221228211059
ACCESSION NUMBER: 0001104659-22-130631
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221227
FILED AS OF DATE: 20221228
DATE AS OF CHANGE: 20221228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lizak Carol R.
CENTRAL INDEX KEY: 0001785794
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36714
FILM NUMBER: 221496173
MAIL ADDRESS:
STREET 1: 201 MISSION STREET, SUITE 2375
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jaguar Health, Inc.
CENTRAL INDEX KEY: 0001585608
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 PINE STREET SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-371-8300
MAIL ADDRESS:
STREET 1: 200 PINE STREET SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
FORMER COMPANY:
FORMER CONFORMED NAME: Jaguar Animal Health, Inc.
DATE OF NAME CHANGE: 20130830
4
1
tm2233639-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-12-27
0
0001585608
Jaguar Health, Inc.
JAGX
0001785794
Lizak Carol R.
C/O JAGUAR HEALTH, INC.
200 PINE STREET, SUITE 400
SAN FRANCISCO
CA
94104
0
1
0
0
Chief Financial Officer
Employee Stock Option (right to buy)
5.97
2022-12-27
4
D
0
14294
0
D
2031-04-05
Common Stock
14294
0
D
The option was cancelled by mutual agreement of the reporting person and Jaguar Health, Inc. The reporting person received $300 as consideration for the cancellation.
The option will vest ratably on a monthly basis over 36 months from the grant date, so long as the executive remains employed by the issuer.
/s/ Carol R. Lizak
2022-12-28